SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Elan Corporation, plc (ELN)
An SI Board Since October 1996
Posts SubjectMarks Bans Symbol
10345 171 0 ELN
Emcee:  Harold Engstrom Type:  Moderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
9895Fat chance for generic competition. But here's some patents for you to look rkrw-8/9/2008
9894When do Tysabri's patents expire ? Anybody see reported patent protection bQualified Opinion-8/9/2008
9893<b>Tysabri Forecasts Are Unrealistic, Say Analysts</b> boston.com DewDiligence_on_SI-8/6/2008
9892<i>>monotherapy in Europe? my foot. it would not surprise me if the 2 PDewDiligence_on_SI-8/6/2008
9891monotherapy in Europe? my foot. it would not surprise me if the 2 PML cases werebauke j deinum-8/6/2008
9890More likely scenario imo seems to be on/off period. These are drugs for life, serkrw-8/5/2008
9889You are right of course. We have little direct data but from what I know which kenhott-8/5/2008
9888So I am not arguing that the tap tap tap way is better than TOUCH if the PML ratkenhott-8/5/2008
9887Elan's bapineuzumab Look at slide 15 at a dose of 0.15 mg/kg, then look at georgejjl1-8/5/2008
9886One more thought: there is not enough data on how a drug holiday might impact thidos-8/5/2008
9885I would add Rituxan (regardless of its failure in PPMS) and ocrelizumab (2nd genidos-8/5/2008
9884<i>Not pleasant for the patient and that's a lot of taps for some of tDewDiligence_on_SI-8/4/2008
9883Not saying its inappropriate but I can't imagine doing taps every couple of rkrw-8/4/2008
9882j. birchenough on ty re: biib; the leh eln analyst has not issued an update sincsoftware salesperson-8/4/2008
9881Thanks Ken, if you run into slides of Bap brain penetration, pass them on.. Whazeta1961-8/4/2008
9880I would argue that TOUCH (and EU) were defense type programs, a small part havinkenhott-8/4/2008
9879Notable calls brings Leerink back to comment on the PML issue. notablecalls.btuck-8/4/2008
9878Just a quick drive thru comment. I had commented before that Flu was a kitchen kenhott-8/4/2008
9877<maybe we need to have checks for JCV in the csf, would mean LP's every 2kenhott-8/4/2008
9876Looks like an update was n=200, n=7 with JC/BK. All n=7 returned to negative afkenhott-8/4/2008
9875ELN — An Unusual Feat The pcyhuang-8/3/2008
9874Challenging prognosis for Elan need not be terminal: Monday, August 4, 2008 MondAsymmetric-8/3/2008
9873nationalmssociety.orgleigh aulper-8/3/2008
9872>- maybe we need to have checks for JCV in the csf, would mean LP's everyidos-8/3/2008
9871Flurizan data at ICAD, BBB in alzheimer patients..here's a really interestinzeta1961-8/2/2008
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News